Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil

NCT00524745 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

903

Enrollment

OTHER

Sponsor class

Conditions

Dose Schedule Study

Interventions

BIOLOGICAL: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine

Sponsor

PATH

Collaborators

[object Object]